Published in Eur J Pharmacol on July 14, 1999
Mechanisms regulating cytochrome c release in pancreatic mitochondria. Gut (2008) 1.58
Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species. J Physiol (2004) 1.02
Organellar dysfunction in the pathogenesis of pancreatitis. Antioxid Redox Signal (2011) 0.97
Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol (2006) 0.92
Ethyl pyruvate significantly inhibits tumour necrosis factor-α, interleukin-1β and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury. Clin Exp Immunol (2013) 0.86
Preventive Effect of Cichorium Intybus L. Two Extracts on Cerulein-induced Acute Pancreatitis in Mice. Int J Prev Med (2012) 0.86
Safety and efficacy of vitamin-based antioxidant therapy in patients with severe acute pancreatitis: a randomized controlled trial. Saudi J Gastroenterol (2011) 0.82
Role of vitamins in gastrointestinal diseases. World J Gastroenterol (2015) 0.82
n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats? Int J Colorectal Dis (2005) 0.81
Autophagy in alcohol-induced multiorgan injury: mechanisms and potential therapeutic targets. Biomed Res Int (2014) 0.81
Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats. World J Gastroenterol (2006) 0.81
Potential role of NADPH oxidase in pathogenesis of pancreatitis. World J Gastrointest Pathophysiol (2014) 0.80
Hydrogen-rich saline inhibits NLRP3 inflammasome activation and attenuates experimental acute pancreatitis in mice. Mediators Inflamm (2014) 0.80
Sulforaphane Protects Pancreatic Acinar Cell Injury by Modulating Nrf2-Mediated Oxidative Stress and NLRP3 Inflammatory Pathway. Oxid Med Cell Longev (2016) 0.79
Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-κB. Int J Clin Exp Pathol (2014) 0.79
Membrane proteome analysis of cerulein-stimulated pancreatic acinar cells: implication for early event of acute pancreatitis. Gut Liver (2010) 0.78
Oxygen radical formation does not have an impact in the treatment of severe acute experimental pancreatitis using free cellular hemoglobin. World J Gastroenterol (2006) 0.78
Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats. World J Gastroenterol (2013) 0.78
Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Sci Rep (2016) 0.78
Use of activated protein C has no avail in the early phase of acute pancreatitis. HPB (Oxford) (2008) 0.78
The beneficial effects of pentoxifylline on caerulein-induced acute pancreatitis in rats. Dig Dis Sci (2008) 0.78
Preventive Effect of Three Pomegranate (Punica granatum L.) Seeds Fractions on Cerulein-Induced Acute Pancreatitis in Mice. Int J Prev Med (2014) 0.78
Cytokine release, pancreatic injury, and risk of acute pancreatitis after spinal fusion surgery. Dig Dis Sci (2004) 0.77
Pancreatic injury after major hepatectomy: a study in a porcine model. Surg Today (2011) 0.77
Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. Int J Mol Med (2015) 0.77
Antioxidative phytoceuticals to ameliorate pancreatitis in animal models: an answer from nature. World J Gastroenterol (2014) 0.75
Evidence for a role of mitogen-activated protein kinases in the treatment of experimental acute pancreatitis. World J Gastroenterol (2014) 0.75
Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology (1974) 2.87
Spontaneous flow of bile through the human pancreatic duct in the absence of pancreatitis: nature's human experiment. Endoscopy (2003) 1.95
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. Gastroenterology (1976) 1.74
Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion (1987) 1.69
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol (2011) 1.62
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis (2001) 1.59
Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol (2002) 1.55
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology (1981) 1.52
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology (1975) 1.49
Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology (1981) 1.40
Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol (2004) 1.32
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis (1974) 1.32
Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol (2009) 1.31
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Am J Dig Dis (1968) 1.28
Effect of medical and surgical vagotomy on gastric response to graded doses of pentagastrin and histamine. Gastroenterology (1968) 1.28
Distribution and release of epidermal growth factor in man. Gut (1989) 1.25
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut (1987) 1.24
Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther (2000) 1.23
Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol (1975) 1.23
Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut (1979) 1.22
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest (1976) 1.22
Gastric cytoprotection. Scand J Gastroenterol (1985) 1.21
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut (1981) 1.21
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. J Physiol (1976) 1.19
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept (2004) 1.18
Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis. Thromb Diath Haemorrh (1968) 1.18
Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. Gastroenterology (1976) 1.18
The effect of secretin on gastric acid secretion and peptic ulcers induced by pentagastrin in cats with intact or resected duodenum. Am J Dig Dis (1968) 1.17
Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol (2011) 1.16
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur J Pharmacol (1999) 1.14
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol (2007) 1.14
Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci (1982) 1.12
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. Gastroenterology (1974) 1.12
The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion. Scand J Gastroenterol (1969) 1.12
Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol (2003) 1.11
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10
Effect of vagotomy on hormones stimulating pancreatic secretion. Arch Surg (1974) 1.09
Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroenterol (1991) 1.09
Apoptosis in gastric mucosa with stress-induced gastric ulcers. J Physiol Pharmacol (1999) 1.08
Effect of exclusion, acidification, and excision of the duodenum on gastric acid secretion and the production of pentagastrin-induced peptic ulcers in cats. Gastroenterology (1969) 1.08
Gastrin-like pentapeptide I.C.I. 50 123: a potent gastric stimulant in man. Am J Dig Dis (1967) 1.08
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins. Gut (1987) 1.08
Effect of calcium and calcitonin on gastrin and gastric secretion in cats. Am J Physiol (1973) 1.07
Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol (2004) 1.07
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther (1999) 1.07
Effects of epidermal growth factor on gastrointestinal secretions. Am J Physiol (1984) 1.05
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin. Gastroenterology (1976) 1.05
Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate. Scand J Gastroenterol Suppl (1986) 1.04
Oxygen-derived free radicals in cerulein-induced acute pancreatitis. Scand J Gastroenterol (1988) 1.04
Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit (2001) 1.03
Effect of glucagon on gastric and pancreatic secretion and peptic ulcer formation in cats. Am J Dig Dis (1974) 1.03
Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci (2003) 1.03
Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J Physiol Pharmacol (2003) 1.03
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Gastroenterology (1975) 1.03
Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol (2009) 1.02
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers. Eur J Pharmacol (2000) 1.02
Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. Gastroenterology (1980) 1.02
Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology (1990) 1.02
Association of the presence of Helicobacter pylori in the oral cavity and in the stomach. J Physiol Pharmacol (2004) 1.02
Gastroprotective effects of flavonoids in plant extracts. J Physiol Pharmacol (2005) 1.02
Melatonin and aging: prospects for human treatment. J Physiol Pharmacol (2011) 1.01
Gastric acid does drive pancreatic bicarbonate secretion. Scand J Gastroenterol (1974) 1.01
Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer. Gut (1981) 1.01
Neuro-hormonal control of food intake: basic mechanisms and clinical implications. J Physiol Pharmacol (2005) 1.01
Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J Physiol Pharmacol (2005) 1.01
Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology (1976) 1.00
Prostaglandins and alkaline secretion from oxyntic, antral, and duodenal mucosa of the dog. Am J Physiol (1983) 1.00
Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol (2006) 1.00
Effects of nicotine on gastrointestinal secretions.. Gastroenterology (1971) 1.00
Inhibition of pancreatic secretion by enkephalin and morphine in dogs. Gastroenterology (1978) 0.99
Effect of secretin and jejunal acidification on gastric and pancreatic secretion in man. Gut (1970) 0.99
Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. J Physiol Pharmacol (2004) 0.99
Characteristics of intestinal phase of gastric secretion. Am J Physiol (1976) 0.99
Serum gastrin and gastric acid responses to meals at various pH levels in man. Gut (1974) 0.98
Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis (2001) 0.98
Effect of carprofen and indomethacin on gastric function, mucosal integrity and generation of prostaglandins in men. Hepatogastroenterology (1982) 0.97
Pancreatic dose-response curves to intravenous secretin in man. Gastroenterology (1970) 0.97
Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther (2001) 0.97
Cannabinoids in acute gastric damage and pancreatitis. J Physiol Pharmacol (2006) 0.97
Effect of atropine on gastrin and gastric acid response to peptone meal. J Clin Invest (1974) 0.96
Effect of exogenous and endogenous secretin on gastric and pancreatic secretion in cats. Am J Physiol (1969) 0.96
Somatostatin and the gastrointestinal secretions. Scand J Gastroenterol (1976) 0.96
Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins. Gut (1982) 0.96
Effect of diversion and replacement of bile on pancreatic secretion. Am J Dig Dis (1973) 0.96
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol (1994) 0.96
Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut (1983) 0.96
Leptin modulates the inflammatory response in acute pancreatitis. Digestion (2002) 0.95